In September 2011, the United Nations held a high level meeting (heads of state) that concluded that the global burden of noncommunicable diseases posed a threat to development and that identified reducing tobacco use (together with unhealthy diet, physical inactivity, and harmful use of alcohol) as key to reducing the growing global burden of heart and other noncommunicable diseases.[1] While it is widely accepted that tobacco is responsible for a significant disease burden and that reducing tobacco use will reduce these diseases,[2] it is less well-appreciated that reducing exposure to secondhand tobacco smoke produces large and rapid reductions in heart disease-related events, including hospitalization for acute myocardial infarction (AMI).[3]
Secondhand smoke (SHS) is a combination of the sidestream smoke from the lit end of a burning cigarette and smoke exhaled by smokers. It is a complex mixture particles and gases, many of which are cardiac toxicants or irritants. SHS is rich in very fine respiratory suspended particulates (RSP) that promote atherosclerosis and trigger heart attacks,[4] so it is not surprising that in 2005 the California Environmental Protection Agency[5] and in 2006 the U.S. Surgeon General concluded that SHS causes coronary heart disease (CHD) morbidity and mortality,[6] with exposure being associated with a 25–30% increased risk. This finding is consistent with the fact that involuntary smokers experience oxidative stress, systemic inflammation, abnormal platelet activation and thrombosis, vascular endothelial dysfunction, and a lowered HDL/LDL ratio and hyperlipidemia, all of which contribute to atherosclerosis, as well as autonomic abnormalities of the heart and vasculature that may trigger a cardiac event.[7, 8] While secondhand smoke is richer in many toxins than mainstream smoke (which is inhaled by smokers),[9] it is more diluted, so involuntary smokers are exposed to substantially smaller doses of these toxins than active smokers. As a result, the 25–30% increase in risk of a cardiac event in involuntary smokers may seem large (compared to the risk of active smoking of 39% for 1 cigarette/day and 78% for 20 cigarettes/day[10]). The explanation for these findings is that the response of the cardiovascular system to the toxins in tobacco smoke is highly nonlinear, with large incremental effects at low doses that tend to saturate at higher levels of exposure.[4, 7, 8, 11]
Immediate Cardiovascular Benefits of Comprehensive Laws
Given what we know about the biology, one would expect that policies that eliminate SHS exposure should have a substantial effect on cardiac events, something first observed in Helena, Montana (USA) where there was a substantial drop in hospital admissions for acute myocardial infarction following implementation of a comprehensive (workplaces, restaurants and bars) 100% smokefree law.[12] By 2009, this literature had grown to 13 studies, which were the subject of two meta-analyses[13, 14], which concluded that there was a 14–17% reduction in hospital admissions for acute myocardial infarctions one year after implementing comprehensive smokefree laws. The following year, another meta-analysis[15] found a 10% reduction in an expanded set of cardiac outcomes (AMI, acute coronary syndrome, coronary heart disease, and ischemic heart disease). Since then, the evidence that comprehensive smokefree laws are followed by reductions in acute myocardial infarctions has continued to accumulate rapidly.
There have also been similar studies of the effects of these laws on hospital admissions for other cardiac outcomes – angina,[16–20] acute coronary syndrome,[21–24] acute coronary events,[25] ischemic heart disease,[26] coronary heart disease,[27] and sudden cardiac death[28] – which also show immediate reductions in events.
Not surprisingly, the tobacco companies have mounted a campaign to undermine the evidence linking smoking and secondhand smoke to heart disease. They conducted early experiments examining these links, and when results showed positive results unfavorable to the tobacco companies, they disputed and ultimately defunded the research; more recently, large studies examining SHS exposure and cardiovascular disease have presented findings that are negative or suggest a lower magnitude of effect due to misclassification.[29] Consistent with this pattern of behavior, a 2011 meta-analysis by a long-time tobacco industry consultant[30] funded by Japan Tobacco International estimated a smaller effect, but even he could not deny that SHS is associated with a reduction in AMI. (Studies funded by the tobacco industry consistently find smaller or no risks associated with secondhand smoke.[31])
Conclusion
As of 2004 an estimated 40% of children, 33% of non-smoking men, and 35% of nonsmoking women were exposed to secondhand smoke globally.[32] Six hundred thousand deaths worldwide per year are attributable to secondhand smoke, translating to 10.9 million disability-adjusted life-years lost.[32]
Comprehensive smokefree laws that prohibit smoking in workplaces, restaurants, bars, and casinos represent an opportunity to protect the public health by reducing the risk of cardiovascular disease and other SHS-related diseases. When laws are not comprehensive and permit smoking in any public place, such as bars or casinos, or in some sections of an otherwise smokefree establishment, they are less effective. For example, workplaces policies that permit smoking in some areas are about half as effective in reducing consumption and smoking prevalence as fully smokefree workplace policies.[33] The people who work and play in these settings are deprived of the full cardiovascular benefits of a smokefree environment;[34] therefore, exceptions or loopholes in smokefree laws raise an issue of justice in public health ethics.
As of 2009 89% of the world’s population lived without comprehensive smokefree laws.[35] While there has been progress since then, much remains to be done. The World Health Organization Framework Convention on Tobacco Control, [36] which had 174 parties as of January 2012, commits parties to implementating smokefree legislation:
Each Party shall adopt and implement in areas of existing national jurisdiction as determined by national law and actively promote at other jurisdictional levels the adoption and implementation of effective legislative, executive, administrative, and/or other measures, providing for protection from exposure to tobacco smoke in indoor workplaces, public transport, indoor public places, and as appropriate, other public places. [36, Article 8]
Strongly enforced comprehensive smokefree legislation will prevent morbidity and mortality associated with secondhand smoke, and countries that have not already implemented such policies should consider doing so for the protection and well-being of their citizens.
Acknowledgments
Funding/Support: This work was supported by National Cancer Institute grants CA-61021 and CA- 87472.
Role of the Sponsors: The funding agency played no role in the collection analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.
Footnotes
Submission Declaration: This work has not been published previously and is not under consideration for publication elsewhere. Publication is approved by all. If accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.
Conflict of Interest: Authors report no conflict of interest including any financial, personal or other relationships with other people or organizations that could inappropriately influence, or be perceived to influence, their work.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- 1.UN General Assembly. Draft resolution: Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases; Sept 16, 2011 Dec 22, 2011; Available from: http://www.un.org/ga/search/viewdoc.asp?symbol=A/66/L.l&referer=http://www.ghd-net.org/negotiations/un-summit-non-communicable-diseases/official-documents&Lang=E. [Google Scholar]
- 2.Beaglehole R, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438–47. doi: 10.1016/S0140-6736(11)60393-0. [DOI] [PubMed] [Google Scholar]
- 3.Glantz S, Gonzalez M. Effective tobacco control is key to rapid progress in reduction of non-communicable diseases. Lancet. 2011 doi: 10.1016/S0140-6736(11)60615-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Pope CA, 3rd, et al. Cardiovascular mortality and exposure to airborne fine particulate matter and cigarette smoke: shape of the exposure-response relationship. Circulation. 2009;120(11):941–8. doi: 10.1161/CIRCULATIONAHA.109.857888. [DOI] [PubMed] [Google Scholar]
- 5.California Environmental Protection Agency. Health Effects of Exposure to Environmental Tobacco Smoke. 2005. [Google Scholar]
- 6.Centers for Disease Control and Prevention. The Health Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. Atlanta, GA: 2006. [PubMed] [Google Scholar]
- 7.Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005;111(20):2684–98. doi: 10.1161/CIRCULATIONAHA.104.492215. [DOI] [PubMed] [Google Scholar]
- 8.Institute of Medicine. Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence. Washington, DC: 2010. [PubMed] [Google Scholar]
- 9.National Toxicology, P. NTP 12th Report on Carcinogens. Rep Carcinog. 2011;12:iii-499. [PubMed] [Google Scholar]
- 10.Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ. 1997;315(7114):973–80. doi: 10.1136/bmj.315.7114.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Centers for Disease Control and Prevention. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: 2010. [PubMed] [Google Scholar]
- 12.Sargent RP, Shepard RM, Glantz SA. Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ. 2004;328(7446):977–80. doi: 10.1136/bmj.38055.715683.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Lightwood JM, Glantz SA. Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation. 2009;120(14):1373–9. doi: 10.1161/CIRCULATIONAHA.109.870691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Meyers DG, Neuberger JS, He J. Cardiovascular effect of bans on smoking in public places: a systematic review and meta-analysis. J Am Coll Cardiol. 2009;54(14):1249–55. doi: 10.1016/j.jacc.2009.07.022. [DOI] [PubMed] [Google Scholar]
- 15.Mackay DF, et al. Meta-analysis of the effect of comprehensive smoke-free legislation on acute coronary events. Heart. 2010;96(19):1525–30. doi: 10.1136/hrt.2010.199026. [DOI] [PubMed] [Google Scholar]
- 16.Naiman A, Glazier RH, Moineddin R. Association of anti-smoking legislation with rates of hospital admission for cardiovascular and respiratory conditions. CMAJ. 2010;182(8):761–7. doi: 10.1503/cmaj.091130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Herman PM, Walsh ME. Hospital admissions for acute myocardial infarction, angina, stroke, and asthma after implementation of Arizona’s comprehensive statewide smoking ban. Am J Public Health. 2011;101(3):491–6. doi: 10.2105/AJPH.2009.179572. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Sargent JD, et al. Smoking Restrictions and Hospitalization for Acute Coronary Events in Germany. Clin Res Cardiol. doi: 10.1007/s00392-011-0385-1. (in press) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Cronin EM, et al. Impact of a National Smoking Ban on Hospital Admission for Acute coronary Syndromes: A Longitudinal Study. Clin Cardiol. doi: 10.1002/clc.21014. (in press) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Kent BD, Sulaiman I, Nicholson TT, Lane SJ, Moloney ED. Acute pulmonary admissions following implementation of a national workplace smoking ban. Chest 2012. 2012 Mar 1; doi: 10.1378/chest.11-2757. [Epub ahead of print]. doi.10.1378/chest.11-2757. [DOI] [PubMed] [Google Scholar]
- 21.Pell JP, et al. Smoke-free legislation and hospitalizations for acute coronary syndrome. N Engl J Med. 2008;359(5):482–91. doi: 10.1056/NEJMsa0706740. [DOI] [PubMed] [Google Scholar]
- 22.Gudnason T, Viktorsson T, Andersen K. A Smoking Ban in Public Places May Reduce the Incidence of Acute Coronary Syndrome Among Non-smoking Men. Eur Heart J. 2009;30:153. (Abstract Supplement) [Google Scholar]
- 23.Ferrante D, et al. Reduction in hospital admissions for acute coronary syndrome after the successful implementation of 100% smoke-free legislation in Argentina: a comparison with partial smoking restrictions. Tob Control. 2011 doi: 10.1136/tc.2010.042325. [DOI] [PubMed] [Google Scholar]
- 24.Gupta R, et al. Clean indoor air regulation and incidence of hospital admissions for acute coronary syndrome in Kanawha County, West Virginia. Prev Chronic Dis. 2011;8(4):A77. [PMC free article] [PubMed] [Google Scholar]
- 25.Cesaroni G, et al. Effect of the Italian smoking ban on population rates of acute coronary events. Circulation. 2008;117(9):1183–8. doi: 10.1161/CIRCULATIONAHA.107.729889. [DOI] [PubMed] [Google Scholar]
- 26.Barone-Adesi F, et al. Effects of Italian smoking regulation on rates of hospital admission for acute coronary events: a country-wide study. PLoS One. 2011;6(3):e17419. doi: 10.1371/journal.pone.0017419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Khuder SA, et al. The impact of a smoking ban on hospital admissions for coronary heart disease. Prev Med. 2007;45(1):3–8. doi: 10.1016/j.ypmed.2007.03.011. [DOI] [PubMed] [Google Scholar]
- 28.Hurt RD, et al. Myocardial Infarction and Sudden Cardiac Death in Olmsted County, Minnesota, Before and After Smoke-Free Workplace Laws. 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Tong EK, Glantz SA. Tobacco industry efforts undermining evidence linking secondhand smoke with cardiovascular disease. Circulation. 2007;116(16):1845–54. doi: 10.1161/CIRCULATIONAHA.107.715888. [DOI] [PubMed] [Google Scholar]
- 30.Lee PN, Fry JS. Reassessing the evidence relating smoking bans to heart disease. Regul Toxicol Pharmacol. 2011;61(3):318–31. doi: 10.1016/j.yrtph.2011.09.002. [DOI] [PubMed] [Google Scholar]
- 31.Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA. 1998;279(19):1566–70. doi: 10.1001/jama.279.19.1566. [DOI] [PubMed] [Google Scholar]
- 32.Oberg M, et al. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet. 2011;377(9760):139–46. doi: 10.1016/S0140-6736(10)61388-8. [DOI] [PubMed] [Google Scholar]
- 33.Fichtenberg CM, Glantz SA. Effect of smoke-free workplaces on smoking behaviour: systematic review. BMJ. 2002;325(7357):188. doi: 10.1136/bmj.325.7357.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Hahn EJ, et al. Smoke-free laws, gender, and reduction in hospitalizations for acute myocardial infarction. Public Health Rep. 2011;126(6):826–33. doi: 10.1177/003335491112600608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.WHO Report on the Global Tobacco Epidemic, 2011: Warning about the Dangers of Tobacco. World Health Organization; Geneva, Switzerland: 2011. [Google Scholar]
- 36.World Health Organization. WHO Framework Convention on Tobacco Control. Geneva, Switzerland: 2003. [Google Scholar]
